查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2146847

Ⅱ類人工智慧醫療影像軟體市場：全球市場預測，2026-2032年

Class II AI Medical Imaging Software Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，II 類 AI 醫學影像軟體市場將成長至 14.383 億美元，複合年成長率為 8.54%。

主要市場統計數據
基準年 2025 8.101億美元
預計年份：2026年 8.7507億美元
預測年份 2032 14.383億美元
複合年成長率 (%) 8.54%

Ⅱ類人工智慧醫學影像軟體：概述

II類人工智慧醫學影像軟體在受監管的醫療設備框架內運行，支援診斷影像的分析、優先排序、視覺化和工作流程管理。其價值提案在於提高臨床一致性、減少不必要的延誤，並幫助醫療專業人員應對日益成長的影像任務量。部署資格取決於已證實的臨床效用、監管部門的批准、互通性、網路安全以及與現有放射科和醫院工作流程的整合。

法規、工作流程和證據的變化正在重塑實施方式。

目前的情況正從實驗演示階段轉向臨床管理部署。採購方越來越注重從證據品質、預期用途的清晰度、人工監督、上市後監測、資料保護以及與現有影像和醫療資訊系統的兼容性等因素來評估軟體。儘管報銷的不確定性、採購的複雜性和監管要求的差異性仍然是重要的障礙，但對標準化報告、雲端整合和營運效率的需求正在推動軟體的普及。

人工智慧將增強臨床能力，但不會取代臨床管治。

人工智慧 (AI) 正在增強檢測模式、確定緊急檢測優先順序、量化疾病特徵以及自動化重複性影像處理任務的能力。其累積影響取決於具有代表性的訓練數據、跨掃描儀和臨床環境的可靠檢驗、透明的性能評估以及適當的臨床醫生審查。持續監測和明確的升級程序對於偏差、資料集偏移、假陽性、假陰性、可解釋性限制和自動化偏差至關重要。

每個地區的具體情況都造就了獨特的實施方案。

北美地區擁有先進的數位基礎設施、完善的影像網路，並高度重視監管和臨床證據。歐洲則將成熟的醫療保健系統與隱私、醫療設備和人工智慧管治的嚴格要求結合。亞太地區呈現出顯著的區域差異，既有技術先進的系統，也有快速發展的數位醫療能力。中東地區正在投資建構集中式、數位化醫療服務體系，而非洲則面臨基礎設施和人力資源的限制，但其潛力在於能夠從高度擴充性的決策支援工具中獲益。拉丁美洲對影像現代化的興趣日益濃厚，但這種發展勢頭受到資訊交流不平衡、採購資源匱乏以及監管成熟度不足的限制。

經濟和安全聯盟會影響標準和採購。

東協市場在監管進展、基礎設施和專家資源方面差異顯著，這為互通性和適應性強的解決方案創造了機會。金磚國家成員國在公共衛生優先事項、國家技術能力和資料管治模式方面呈現多樣性。歐盟的部署受到隱私、醫療設備和人工智慧方面要求一致性的影響。七國集團（G7）系統通常強調臨床證據、網路安全和整合。海灣合作理事會（GCC）國家注重數位化醫療保健和大量投資，而北約成員國除了性能之外，也越來越重視韌性、安全的基礎設施和臨床運作的連續性。

每個國家的實際情況將決定實施的優先順序。

澳洲和加拿大優先考慮地域分散的醫療保健、互通性和公平取得。巴西、墨西哥、印度和南非必須在不斷成長的需求與不均衡的基礎設施、人力資源能力和採購限制之間取得平衡。中國、日本和韓國擁有高超的技術能力，但面臨獨特的監管、數據和醫療保健系統要求。法國、德國、義大利、西班牙和英國特別重視公共部門的證據、隱私、工作流程整合和價值。美國擁有成熟的診斷成像生態系統，並嚴格關注核准、臨床驗證、網路安全和營運課責。俄羅斯的部署環境受其國內基礎設施、監管環境和准入因素的影響。

優先考慮基於管治的實施、互通性和可衡量的臨床價值。

產業領導者在擴大部署規模之前，應明確定義具有臨床意義且範圍有限的「預期用途」。他們還應建立機制，檢驗其在相關目標族群、治療模式、醫療設備以及整個醫療保健環境中的效能，並監測偏差、偏差、安全事件和工作流程影響。解決方案必須與現有的影像和臨床系統整合，提供易於理解的解釋和可靠性指標，並確保臨床醫生能夠掌控一切。籌資策略不應僅依賴技術效能，還應涵蓋網路安全、資料儲存、生命週期支援、培訓、變更管理以及透明的效能指標。

調查方法：基於證據的監管和臨床促進因素整合。

本執行摘要整合了所呈現的市場範圍以及與 II 類人工智慧醫學影像軟體相關的既定且公開記錄的考慮因素，包括醫療設備監管、臨床檢驗、健康數據管治、互通性、網路安全以及指定區域和國家群體中的醫療服務條件。本分析採用質性和比較性方法。市場規模估算、市場規模計算、市場佔有率、預測以及針對特定公司的評估均未包含在內。

可靠的整合對於永續部署至關重要。

二類人工智慧醫學影像軟體若不以孤立演算法的形式部署，而是作為管治的臨床支援功能，則可顯著提升診斷工作流程。永續部署取決於可靠的證據、合規的監管要求、代表性的數據、安全的互通性、臨床醫生的參與以及持續的部署後監測。將人工智慧性能與可衡量的患者療效和營運結果掛鉤的機構，將更有利於在保障安全、公平和專業課責的同時，實現其價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：II類人工智慧醫學影像軟體市場：依影像方式分類

  • 電腦斷層掃描（CT）
  • 磁振造影（MRI）
  • 正子斷層掃描（PET）
  • 超音波
  • X光

第8章：II類人工智慧醫療影像軟體市場：依軟體類型分類

  • 整合軟體
  • 獨立軟體

第9章：II類人工智慧醫學影像軟體市場：按演算法類型分類

  • 深度學習
    • 卷積類神經網路
    • 生成式網路與反網路
    • 循環神經網路
  • 機器學習
    • 隨機森林
    • 支援向量機

第10章：II類人工智慧醫療影像軟體市場：依應用領域分類

  • 循環系統
    • 心律不整檢測
    • 缺血性心臟病
    • 心臟衰竭
  • 神經病學
    • 阿茲海默症檢測
    • 多發性硬化症
    • 中風偵測
  • 腫瘤學
    • 乳癌檢測
    • 結腸癌的檢測
    • 肺癌檢測
    • 攝護腺癌檢測
  • 眼科
    • 糖尿病視網膜病變
    • 青光眼檢測
    • 黃斑部病變
  • 整形外科
    • 骨骼密度分析
    • 骨折檢測
    • 聯合分析

第11章：II類人工智慧醫療影像軟體市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 診斷中心
  • 醫院

第12章：II類人工智慧醫療影像軟體市場：依部署模式分類

  • 雲
  • 現場

第13章：II類人工智慧醫療影像軟體市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：II類人工智慧醫療影像軟體市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：II類人工智慧醫療影像軟體市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Agfa-Gevaert NV
  • Arterys Inc.
  • Canon Medical Systems Corporation
  • Caption Health, Inc.
  • Cleerly, Inc.
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Subtle Medical, Inc.

第18章 主要專家

Product Code: MRR-3D150775E43F

The Class II AI Medical Imaging Software Market is projected to grow by USD 1,438.30 million at a CAGR of 8.54% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 810.10 million
Estimated Year [2026] USD 875.07 million
Forecast Year [2032] USD 1,438.30 million
CAGR (%) 8.54%

Class II AI Medical Imaging Software: Executive Overview

Class II AI medical imaging software supports the analysis, prioritization, visualization, and workflow management of diagnostic images while operating within regulated medical-device frameworks. Its value proposition centers on improving clinical consistency, reducing avoidable delays, and helping healthcare professionals manage growing imaging workloads. Adoption depends on demonstrated clinical utility, regulatory authorization, interoperability, cybersecurity, and integration into established radiology and hospital workflows.

Regulatory, Workflow, and Evidence Shifts Reshape Adoption

The landscape is shifting from experimental demonstrations toward clinically governed deployment. Buyers increasingly assess software through evidence quality, intended-use clarity, human oversight, post-market monitoring, data protection, and compatibility with existing imaging and health-information systems. Reimbursement uncertainty, procurement complexity, and variation in regulatory requirements remain material barriers, while standardized reporting, cloud-enabled collaboration, and demand for operational efficiency support implementation.

Artificial Intelligence Extends Capacity but Does Not Replace Clinical Governance

Artificial intelligence is increasing the ability to detect patterns, prioritize urgent studies, quantify disease characteristics, and automate repetitive image-processing tasks. Its cumulative impact depends on representative training data, robust validation across scanners and care settings, transparent performance measurement, and appropriate clinician review. Bias, dataset shift, false positives, false negatives, explainability limitations, and automation bias require continuous monitoring and clearly defined escalation pathways.

Regional Conditions Create Distinct Adoption Pathways

North America is characterized by advanced digital infrastructure, established imaging networks, and strong emphasis on regulatory and clinical evidence. Europe combines sophisticated healthcare systems with stringent privacy, medical-device, and AI-governance expectations. Asia-Pacific presents substantial variation, with technologically advanced systems alongside rapidly expanding digital-health capacity. The Middle East is investing in centralized, digitally enabled healthcare delivery, while Africa faces infrastructure and workforce constraints but may benefit from scalable decision-support tools. Latin America shows growing interest in imaging modernization, tempered by uneven connectivity, procurement resources, and regulatory maturity.

Economic and Security Alliances Influence Standards and Procurement

ASEAN markets differ widely in regulatory readiness, infrastructure, and specialist availability, creating opportunities for interoperable and adaptable solutions. BRICS members reflect varied public-health priorities, domestic technology capabilities, and data-governance models. European Union adoption is shaped by coordinated privacy, medical-device, and AI requirements. G7 systems generally place strong weight on clinical evidence, cybersecurity, and integration. GCC countries are emphasizing digitally enabled care and centralized investment, while NATO members increasingly consider resilience, secure infrastructure, and continuity of clinical operations alongside performance.

Country Context Determines Implementation Priorities

Australia and Canada emphasize geographically distributed care, interoperability, and equitable access. Brazil, Mexico, India, and South Africa must balance expanding demand with uneven infrastructure, workforce capacity, and procurement constraints. China, Japan, and South Korea combine substantial technical capabilities with distinctive regulatory, data, and healthcare-system requirements. France, Germany, Italy, Spain, and the United Kingdom place significant emphasis on evidence, privacy, workflow integration, and public-sector value. The United States has a mature imaging ecosystem with rigorous attention to authorization, clinical validation, cybersecurity, and operational accountability. Russia's deployment environment is shaped by domestic infrastructure, regulatory conditions, and access considerations.

Prioritize Governed Deployment, Interoperability, and Measurable Clinical Value

Industry leaders should define narrow, clinically meaningful intended uses before scaling deployment; validate performance across relevant populations, modalities, devices, and care environments; and establish monitoring for drift, bias, safety events, and workflow effects. Solutions should integrate with existing imaging and clinical systems, provide usable explanations and confidence cues, and preserve clinician control. Procurement strategies should include cybersecurity, data residency, lifecycle support, training, change management, and transparent outcome metrics rather than relying on technical performance alone.

Methodology: Evidence-Based Synthesis of Regulatory and Clinical Drivers

This executive summary synthesizes the supplied market scope with established, publicly documented considerations relevant to Class II AI medical imaging software, including medical-device oversight, clinical validation, health-data governance, interoperability, cybersecurity, and healthcare delivery conditions across the specified geographies and country groupings. The analysis is qualitative and comparative. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific assessments.

Sustainable Adoption Depends on Trustworthy Integration

Class II AI medical imaging software can strengthen diagnostic workflows when it is implemented as a governed clinical support capability rather than an isolated algorithm. Durable adoption will depend on credible evidence, regulatory alignment, representative data, secure interoperability, clinician engagement, and continuous post-deployment oversight. Organizations that connect AI performance to measurable patient and operational outcomes will be better positioned to realize value while protecting safety, equity, and professional accountability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Class II AI Medical Imaging Software Market, by Modality

  • 7.1. Introduction
  • 7.2. Computed Tomography
  • 7.3. Magnetic Resonance Imaging
  • 7.4. Positron Emission Tomography
  • 7.5. Ultrasound
  • 7.6. X Ray

8. Class II AI Medical Imaging Software Market, by Software Type

  • 8.1. Introduction
  • 8.2. Integrated Software
  • 8.3. Standalone Software

9. Class II AI Medical Imaging Software Market, by Algorithm Type

  • 9.1. Introduction
  • 9.2. Deep Learning
    • 9.2.1. Convolutional Neural Networks
    • 9.2.2. Generative Adversarial Networks
    • 9.2.3. Recurrent Neural Networks
  • 9.3. Machine Learning
    • 9.3.1. Random Forest
    • 9.3.2. Support Vector Machines

10. Class II AI Medical Imaging Software Market, by Application

  • 10.1. Introduction
  • 10.2. Cardiology
    • 10.2.1. Arrhythmia Detection
    • 10.2.2. Coronary Artery Disease
    • 10.2.3. Heart Failure
  • 10.3. Neurology
    • 10.3.1. Alzheimer's Detection
    • 10.3.2. Multiple Sclerosis
    • 10.3.3. Stroke Detection
  • 10.4. Oncology
    • 10.4.1. Breast Cancer Detection
    • 10.4.2. Colon Cancer Detection
    • 10.4.3. Lung Cancer Detection
    • 10.4.4. Prostate Cancer Detection
  • 10.5. Ophthalmology
    • 10.5.1. Diabetic Retinopathy
    • 10.5.2. Glaucoma Detection
    • 10.5.3. Macular Degeneration
  • 10.6. Orthopedics
    • 10.6.1. Bone Density Analysis
    • 10.6.2. Fracture Detection
    • 10.6.3. Joint Analysis

11. Class II AI Medical Imaging Software Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Clinics
  • 11.4. Diagnostic Centers
  • 11.5. Hospitals

12. Class II AI Medical Imaging Software Market, by Deployment Mode

  • 12.1. Introduction
  • 12.2. Cloud
  • 12.3. On Premise

13. Class II AI Medical Imaging Software Market, by Region

  • 13.1. Introduction
  • 13.2. Asia-Pacific
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Europe
  • 13.6. Middle East
  • 13.7. Africa

14. Class II AI Medical Imaging Software Market, by Group

  • 14.1. Introduction
  • 14.2. ASEAN
  • 14.3. GCC
  • 14.4. European Union
  • 14.5. BRICS
  • 14.6. G7
  • 14.7. NATO

15. Class II AI Medical Imaging Software Market, by Country

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. United Kingdom
  • 15.7. Germany
  • 15.8. France
  • 15.9. Russia
  • 15.10. Italy
  • 15.11. Spain
  • 15.12. China
  • 15.13. India
  • 15.14. Japan
  • 15.15. Australia
  • 15.16. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. Market Concentration Analysis, 2025
    • 16.2.1. Concentration Ratio (CR)
    • 16.2.2. Herfindahl Hirschman Index (HHI)
  • 16.3. Recent Developments & Impact Analysis, 2025
  • 16.4. Product Portfolio Analysis, 2025
  • 16.5. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Agfa-Gevaert N.V.
  • 17.2. Arterys Inc.
  • 17.3. Canon Medical Systems Corporation
  • 17.4. Caption Health, Inc.
  • 17.5. Cleerly, Inc.
  • 17.6. FUJIFILM Holdings Corporation
  • 17.7. GE HealthCare Technologies Inc.
  • 17.8. Hitachi, Ltd.
  • 17.9. Hologic, Inc.
  • 17.10. Koninklijke Philips N.V.
  • 17.11. Samsung Medison Co., Ltd.
  • 17.12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 17.13. Siemens Healthineers AG
  • 17.14. Subtle Medical, Inc.

18. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Class II AI Medical Imaging Software Market, Years Considered for the Study
  • FIGURE 2. Global Class II AI Medical Imaging Software Market, Research Design
  • FIGURE 3. Global Class II AI Medical Imaging Software Market, Research Framework
  • FIGURE 4. Global Class II AI Medical Imaging Software Market, Data Triangulation
  • FIGURE 5. Global Class II AI Medical Imaging Software Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Class II AI Medical Imaging Software Market Size, by Modality, 2025 vs 2032 (%)
  • FIGURE 7. Global Class II AI Medical Imaging Software Market Size, by Modality, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Class II AI Medical Imaging Software Market Size, by Software Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Class II AI Medical Imaging Software Market Size, by Software Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2025 vs 2032 (%)
  • FIGURE 11. Global Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Class II AI Medical Imaging Software Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 13. Global Class II AI Medical Imaging Software Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Class II AI Medical Imaging Software Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Class II AI Medical Imaging Software Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2025 vs 2032 (%)
  • FIGURE 17. Global Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Class II AI Medical Imaging Software Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 19. Global Class II AI Medical Imaging Software Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global Class II AI Medical Imaging Software Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Class II AI Medical Imaging Software Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 22. Global Class II AI Medical Imaging Software Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 23. Global Class II AI Medical Imaging Software Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Class II AI Medical Imaging Software Market Segmentation & Coverage
  • TABLE 2. Global Class II AI Medical Imaging Software Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 4. Global Computed Tomography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Computed Tomography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Computed Tomography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Magnetic Resonance Imaging Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Magnetic Resonance Imaging Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Magnetic Resonance Imaging Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Positron Emission Tomography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Positron Emission Tomography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Positron Emission Tomography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Ultrasound Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Ultrasound Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Ultrasound Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global X Ray Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global X Ray Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global X Ray Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 20. Global Integrated Software Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Integrated Software Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Integrated Software Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Standalone Software Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Standalone Software Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Standalone Software Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 27. Global Deep Learning Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 28. Global Deep Learning Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 29. Global Deep Learning Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 30. Global Convolutional Neural Networks Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 31. Global Convolutional Neural Networks Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 32. Global Convolutional Neural Networks Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 33. Global Generative Adversarial Networks Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 34. Global Generative Adversarial Networks Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 35. Global Generative Adversarial Networks Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 36. Global Recurrent Neural Networks Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 37. Global Recurrent Neural Networks Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 38. Global Recurrent Neural Networks Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 39. Global Machine Learning Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Machine Learning Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Machine Learning Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Random Forest Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Random Forest Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Random Forest Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Support Vector Machines Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Support Vector Machines Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Support Vector Machines Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 49. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Arrhythmia Detection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Arrhythmia Detection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Arrhythmia Detection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Coronary Artery Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Coronary Artery Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Coronary Artery Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Heart Failure Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Heart Failure Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Heart Failure Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 63. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 64. Global Alzheimer's Detection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 65. Global Alzheimer's Detection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 66. Global Alzheimer's Detection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 67. Global Multiple Sclerosis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 68. Global Multiple Sclerosis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 69. Global Multiple Sclerosis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 70. Global Stroke Detection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. Global Stroke Detection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 72. Global Stroke Detection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 73. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 74. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 75. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 76. Global Breast Cancer Detection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 77. Global Breast Cancer Detection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 78. Global Breast Cancer Detection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 79. Global Colon Cancer Detection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 80. Global Colon Cancer Detection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 81. Global Colon Cancer Detection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 82. Global Lung Cancer Detection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 83. Global Lung Cancer Detection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 84. Global Lung Cancer Detection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 85. Global Prostate Cancer Detection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Global Prostate Cancer Detection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 87. Global Prostate Cancer Detection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 88. Global Ophthalmology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 89. Global Ophthalmology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 90. Global Ophthalmology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 91. Global Diabetic Retinopathy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 92. Global Diabetic Retinopathy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 93. Global Diabetic Retinopathy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 94. Global Glaucoma Detection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 95. Global Glaucoma Detection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 96. Global Glaucoma Detection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 97. Global Macular Degeneration Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 98. Global Macular Degeneration Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 99. Global Macular Degeneration Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 100. Global Orthopedics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 101. Global Orthopedics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 102. Global Orthopedics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 103. Global Bone Density Analysis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 104. Global Bone Density Analysis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 105. Global Bone Density Analysis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 106. Global Fracture Detection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 107. Global Fracture Detection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 108. Global Fracture Detection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 109. Global Joint Analysis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 110. Global Joint Analysis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 111. Global Joint Analysis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 112. Global Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 113. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 114. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 115. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 116. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 117. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 118. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 119. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 120. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 121. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 122. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 123. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 124. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 125. Global Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 126. Global Cloud Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 127. Global Cloud Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 128. Global Cloud Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 129. Global On Premise Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 130. Global On Premise Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 131. Global On Premise Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 132. Global Class II AI Medical Imaging Software Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 133. Asia-Pacific Class II AI Medical Imaging Software Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 134. Asia-Pacific Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 135. Asia-Pacific Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 136. Asia-Pacific Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 137. Asia-Pacific Class II AI Medical Imaging Software Market Size, by Deep Learning, 2017-2032 (USD Million)
  • TABLE 138. Asia-Pacific Class II AI Medical Imaging Software Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 139. Asia-Pacific Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 140. Asia-Pacific Class II AI Medical Imaging Software Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 141. Asia-Pacific Class II AI Medical Imaging Software Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 142. Asia-Pacific Class II AI Medical Imaging Software Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 143. Asia-Pacific Class II AI Medical Imaging Software Market Size, by Ophthalmology, 2017-2032 (USD Million)
  • TABLE 144. Asia-Pacific Class II AI Medical Imaging Software Market Size, by Orthopedics, 2017-2032 (USD Million)
  • TABLE 145. Asia-Pacific Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 146. Asia-Pacific Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 147. North America Class II AI Medical Imaging Software Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 148. North America Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 149. North America Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 150. North America Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 151. North America Class II AI Medical Imaging Software Market Size, by Deep Learning, 2017-2032 (USD Million)
  • TABLE 152. North America Class II AI Medical Imaging Software Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 153. North America Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 154. North America Class II AI Medical Imaging Software Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 155. North America Class II AI Medical Imaging Software Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 156. North America Class II AI Medical Imaging Software Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 157. North America Class II AI Medical Imaging Software Market Size, by Ophthalmology, 2017-2032 (USD Million)
  • TABLE 158. North America Class II AI Medical Imaging Software Market Size, by Orthopedics, 2017-2032 (USD Million)
  • TABLE 159. North America Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 160. North America Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 161. Latin America Class II AI Medical Imaging Software Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 162. Latin America Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 163. Latin America Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 164. Latin America Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 165. Latin America Class II AI Medical Imaging Software Market Size, by Deep Learning, 2017-2032 (USD Million)
  • TABLE 166. Latin America Class II AI Medical Imaging Software Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 167. Latin America Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 168. Latin America Class II AI Medical Imaging Software Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 169. Latin America Class II AI Medical Imaging Software Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 170. Latin America Class II AI Medical Imaging Software Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 171. Latin America Class II AI Medical Imaging Software Market Size, by Ophthalmology, 2017-2032 (USD Million)
  • TABLE 172. Latin America Class II AI Medical Imaging Software Market Size, by Orthopedics, 2017-2032 (USD Million)
  • TABLE 173. Latin America Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 174. Latin America Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 175. Europe Class II AI Medical Imaging Software Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 176. Europe Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 177. Europe Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 178. Europe Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 179. Europe Class II AI Medical Imaging Software Market Size, by Deep Learning, 2017-2032 (USD Million)
  • TABLE 180. Europe Class II AI Medical Imaging Software Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 181. Europe Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 182. Europe Class II AI Medical Imaging Software Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 183. Europe Class II AI Medical Imaging Software Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 184. Europe Class II AI Medical Imaging Software Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 185. Europe Class II AI Medical Imaging Software Market Size, by Ophthalmology, 2017-2032 (USD Million)
  • TABLE 186. Europe Class II AI Medical Imaging Software Market Size, by Orthopedics, 2017-2032 (USD Million)
  • TABLE 187. Europe Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 188. Europe Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 189. Middle East Class II AI Medical Imaging Software Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 190. Middle East Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 191. Middle East Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 192. Middle East Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 193. Middle East Class II AI Medical Imaging Software Market Size, by Deep Learning, 2017-2032 (USD Million)
  • TABLE 194. Middle East Class II AI Medical Imaging Software Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 195. Middle East Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 196. Middle East Class II AI Medical Imaging Software Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 197. Middle East Class II AI Medical Imaging Software Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 198. Middle East Class II AI Medical Imaging Software Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 199. Middle East Class II AI Medical Imaging Software Market Size, by Ophthalmology, 2017-2032 (USD Million)
  • TABLE 200. Middle East Class II AI Medical Imaging Software Market Size, by Orthopedics, 2017-2032 (USD Million)
  • TABLE 201. Middle East Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 202. Middle East Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 203. Africa Class II AI Medical Imaging Software Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 204. Africa Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 205. Africa Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 206. Africa Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 207. Africa Class II AI Medical Imaging Software Market Size, by Deep Learning, 2017-2032 (USD Million)
  • TABLE 208. Africa Class II AI Medical Imaging Software Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 209. Africa Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 210. Africa Class II AI Medical Imaging Software Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 211. Africa Class II AI Medical Imaging Software Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 212. Africa Class II AI Medical Imaging Software Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 213. Africa Class II AI Medical Imaging Software Market Size, by Ophthalmology, 2017-2032 (USD Million)
  • TABLE 214. Africa Class II AI Medical Imaging Software Market Size, by Orthopedics, 2017-2032 (USD Million)
  • TABLE 215. Africa Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 216. Africa Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 217. Global Class II AI Medical Imaging Software Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 218. ASEAN Class II AI Medical Imaging Software Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 219. ASEAN Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 220. ASEAN Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 221. ASEAN Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 222. ASEAN Class II AI Medical Imaging Software Market Size, by Deep Learning, 2017-2032 (USD Million)
  • TABLE 223. ASEAN Class II AI Medical Imaging Software Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 224. ASEAN Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 225. ASEAN Class II AI Medical Imaging Software Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 226. ASEAN Class II AI Medical Imaging Software Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 227. ASEAN Class II AI Medical Imaging Software Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 228. ASEAN Class II AI Medical Imaging Software Market Size, by Ophthalmology, 2017-2032 (USD Million)
  • TABLE 229. ASEAN Class II AI Medical Imaging Software Market Size, by Orthopedics, 2017-2032 (USD Million)
  • TABLE 230. ASEAN Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 231. ASEAN Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 232. GCC Class II AI Medical Imaging Software Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 233. GCC Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 234. GCC Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 235. GCC Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 236. GCC Class II AI Medical Imaging Software Market Size, by Deep Learning, 2017-2032 (USD Million)
  • TABLE 237. GCC Class II AI Medical Imaging Software Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 238. GCC Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 239. GCC Class II AI Medical Imaging Software Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 240. GCC Class II AI Medical Imaging Software Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 241. GCC Class II AI Medical Imaging Software Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 242. GCC Class II AI Medical Imaging Software Market Size, by Ophthalmology, 2017-2032 (USD Million)
  • TABLE 243. GCC Class II AI Medical Imaging Software Market Size, by Orthopedics, 2017-2032 (USD Million)
  • TABLE 244. GCC Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 245. GCC Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 246. European Union Class II AI Medical Imaging Software Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 247. European Union Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 248. European Union Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 249. European Union Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 250. European Union Class II AI Medical Imaging Software Market Size, by Deep Learning, 2017-2032 (USD Million)
  • TABLE 251. European Union Class II AI Medical Imaging Software Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 252. European Union Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 253. European Union Class II AI Medical Imaging Software Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 254. European Union Class II AI Medical Imaging Software Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 255. European Union Class II AI Medical Imaging Software Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 256. European Union Class II AI Medical Imaging Software Market Size, by Ophthalmology, 2017-2032 (USD Million)
  • TABLE 257. European Union Class II AI Medical Imaging Software Market Size, by Orthopedics, 2017-2032 (USD Million)
  • TABLE 258. European Union Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 259. European Union Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 260. BRICS Class II AI Medical Imaging Software Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 261. BRICS Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 262. BRICS Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 263. BRICS Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 264. BRICS Class II AI Medical Imaging Software Market Size, by Deep Learning, 2017-2032 (USD Million)
  • TABLE 265. BRICS Class II AI Medical Imaging Software Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 266. BRICS Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 267. BRICS Class II AI Medical Imaging Software Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 268. BRICS Class II AI Medical Imaging Software Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 269. BRICS Class II AI Medical Imaging Software Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 270. BRICS Class II AI Medical Imaging Software Market Size, by Ophthalmology, 2017-2032 (USD Million)
  • TABLE 271. BRICS Class II AI Medical Imaging Software Market Size, by Orthopedics, 2017-2032 (USD Million)
  • TABLE 272. BRICS Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 273. BRICS Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 274. G7 Class II AI Medical Imaging Software Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 275. G7 Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 276. G7 Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 277. G7 Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 278. G7 Class II AI Medical Imaging Software Market Size, by Deep Learning, 2017-2032 (USD Million)
  • TABLE 279. G7 Class II AI Medical Imaging Software Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 280. G7 Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 281. G7 Class II AI Medical Imaging Software Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 282. G7 Class II AI Medical Imaging Software Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 283. G7 Class II AI Medical Imaging Software Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 284. G7 Class II AI Medical Imaging Software Market Size, by Ophthalmology, 2017-2032 (USD Million)
  • TABLE 285. G7 Class II AI Medical Imaging Software Market Size, by Orthopedics, 2017-2032 (USD Million)
  • TABLE 286. G7 Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 287. G7 Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 288. NATO Class II AI Medical Imaging Software Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 289. NATO Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 290. NATO Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 291. NATO Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 292. NATO Class II AI Medical Imaging Software Market Size, by Deep Learning, 2017-2032 (USD Million)
  • TABLE 293. NATO Class II AI Medical Imaging Software Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 294. NATO Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 295. NATO Class II AI Medical Imaging Software Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 296. NATO Class II AI Medical Imaging Software Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 297. NATO Class II AI Medical Imaging Software Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 298. NATO Class II AI Medical Imaging Software Market Size, by Ophthalmology, 2017-2032 (USD Million)
  • TABLE 299. NATO Class II AI Medical Imaging Software Market Size, by Orthopedics, 2017-2032 (USD Million)
  • TABLE 300. NATO Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 301. NATO Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 302. Global Class II AI Medical Imaging Software Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 303. United States Class II AI Medical Imaging Software Market Size, 2017-2032 (USD Million)
  • TABLE 304. United States Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 305. United States Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 306. United States Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 307. United States Class II AI Medical Imaging Software Market Size, by Deep Learning, 2017-2032 (USD Million)
  • TABLE 308. United States Class II AI Medical Imaging Software Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 309. United States Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 310. United States Class II AI Medical Imaging Software Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 311. United States Class II AI Medical Imaging Software Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 312. United States Class II AI Medical Imaging Software Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 313. United States Class II AI Medical Imaging Software Market Size, by Ophthalmology, 2017-2032 (USD Million)
  • TABLE 314. United States Class II AI Medical Imaging Software Market Size, by Orthopedics, 2017-2032 (USD Million)
  • TABLE 315. United States Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 316. United States Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 317. Canada Class II AI Medical Imaging Software Market Size, 2017-2032 (USD Million)
  • TABLE 318. Canada Class II AI Medical Imaging Software Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 319. Canada Class II AI Medical Imaging Software Market Size, by Software Type, 2017-2032 (USD Million)
  • TABLE 320. Canada Class II AI Medical Imaging Software Market Size, by Algorithm Type, 2017-2032 (USD Million)
  • TABLE 321. Canada Class II AI Medical Imaging Software Market Size, by Deep Learning, 2017-2032 (USD Million)
  • TABLE 322. Canada Class II AI Medical Imaging Software Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 323. Canada Class II AI Medical Imaging Software Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 324. Canada Class II AI Medical Imaging Software Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 325. Canada Class II AI Medical Imaging Software Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 326. Canada Class II AI Medical Imaging Software Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 327. Canada Class II AI Medical Imaging Software Market Size, by Ophthalmology, 2017-2032 (USD Million)
  • TABLE 328. Canada Class II AI Medical Imaging Software Market Size, by Orthopedics, 2017-2032 (USD Million)
  • TABLE 329. Canada Class II AI Medical Imaging Software Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 330. Canada Class II AI Medical Imaging Software Market Size, by Deployment Mode, 2017-2032 (USD Mi